【摘要】 目的 探讨肝动脉化疗栓塞(TACE)联合体部γ刀治疗原发性肝癌(PHC)的疗效。方法 120例PHC患者随机分为介入组与介入加γ刀组(综合组)。介入组60例,行TACE 1～5次,平均3.5次;综合组60例,先行TACE 1～4次,平均3.1次,2～4周后行γ刀治疗。结果 综合组与介入组1、2年生存率分别为90%、76%和78.6%、40%,2组生存率比较差异有显著性(P<0.05)。结论 PHC疗效介入加γ刀优于单纯行TACE治疗,能有效提高生存期,不良反应轻微,是治疗中晚期肝癌的有效方法之一。更多还原

【Abstract】 Objective To evaluate the effect of transcatheter hepatic arterial chemoembolization(TACE) in combination with bodyγ-ray in treatment of primary hepatic carcinoma(PHC).Methods 120 patients with PHC were divided into 2 groups:group A and group B,60 cases in each group.Group A was treated by TACE for 1～4 times with the average value of 3.5 times.Group B was treated by TACE for 1～5 times with the average value of 3.1 times firstly,and 2～4 weeks later,accepted the therapy of γ-ray.Results The survival rate was 90% in 1 year and 76% in 2 yeaars in group B,78.6% and 40% in group A respectively.The difference between 2 groups was statistical significance(P<0.05).Conclusion The treatment of PHC by TACE in combination with body γ-ray can improve the survival rate of patients,which should be advocated for its excellent results and low rate of complications.更多还原